Silymari (Legalon, Siliphos, various generic formulations)
Other
Description
Silymarin is a flavonoid complex extracted from milk thistle (Silybum marianum) that has been evaluated as an adjuvant complementary therapy in metastatic colorectal cancer patients. This herbal compound is being assessed for its potential hepatoprotective and anti-cancer properties when used alongside standard chemotherapy regimens like FOLFIRI. Silymarin represents a natural product approach to potentially enhance treatment outcomes and reduce chemotherapy-related toxicity in CRC patients.
Mechanism of Action
Silymarin exerts its effects through multiple pathways including antioxidant activity, modulation of apoptosis-related proteins such as BCL2, and potential anti-inflammatory mechanisms. The compound may also provide hepatoprotective effects by stabilizing liver cell membranes and promoting hepatocyte regeneration, which could be beneficial for patients receiving hepatotoxic chemotherapy regimens.
Molecular Targets
Side Effects
Not all side effects are listed. Side effects vary by individual. Always consult your oncologist.
Clinical Trials
Quick Info
| Brand Name | Legalon, Siliphos, various generic formulations |
| Category | Other |
 Status | Off-label |
| Administration | Oral |
| Clinical Trials | 2 |
Related Medications
Medical Disclaimer
This information is for educational purposes only and should not replace professional medical advice. Always consult your healthcare team before making treatment decisions.